INS and Hyperglycemia: Additionally, metabolic acidosis, which is a common condition particularly in end-stage renal disease patients [20] and which also promotes inflammation releasing cytokines [21], may be the connective pathophysiological mechanism between hyperglycemia, increased insulin resistance and increased accumulation of beta2Μ [22].